HiRo
Shanghai, China· Est.
Develops innovative RNA interference (RNAi) therapeutics for the treatment of genetic and metabolic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Develops innovative RNA interference (RNAi) therapeutics for the treatment of genetic and metabolic diseases.
RNA TherapeuticsGenetics & GenomicsMetabolic